| Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma (NCT03890952) | Ulrik Lassen | 2018-10-01 |
| Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas (NCT02186509) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-01-30 |
| 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas (NCT02175745) | Erik Mittra | 2014-12-01 |
| Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas (NCT02015819) | City of Hope Medical Center | 2014-10-07 |
| NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma (NCT01894061) | Case Comprehensive Cancer Center | 2013-09-18 |
| Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors (NCT02194452) | Sue O'Dorisio | 2013-09-01 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma (NCT01730950) | Radiation Therapy Oncology Group | 2012-12-20 |
| Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma (NCT01753713) | Manmeet Ahluwalia, MD | 2012-12-20 |
| Carboplatin in Treating Patients With Recurrent High-Grade Gliomas (NCT01644955) | James Elder | 2012-06-11 |
| 3T MRI Biomarkers of Glioma Treatment Response (NCT01996527) | Vanderbilt-Ingram Cancer Center | 2012-05-01 |
| Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme (NCT01575275) | Michael Vogelbaum, MD, PhD | 2012-05-01 |
| Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma (NCT01635283) | Jonsson Comprehensive Cancer Center | 2012-01-10 |
| RO4929097 in Treating Patients With Recurrent Invasive Gliomas (NCT01269411) | National Cancer Institute (NCI) | 2011-07-01 |
| RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma (NCT01189240) | National Cancer Institute (NCI) | 2010-12-01 |
| Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma (NCT01342757) | National Cancer Institute (NCI) | 2010-12-01 |
| Yoga Therapy in Treating Patients With Malignant Brain Tumors (NCT01234805) | Wake Forest University Health Sciences | 2010-12-01 |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases (NCT01234740) | City of Hope Medical Center | 2010-12-01 |
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma (NCT01122901) | National Cancer Institute (NCI) | 2010-12-01 |
| A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas (NCT01172964) | City of Hope Medical Center | 2010-08-01 |
| Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas (NCT01125046) | Northwestern University | 2010-06-17 |
| Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors (NCT01148966) | University of Washington | 2010-06-01 |
| Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma (NCT01103375) | Wake Forest University Health Sciences | 2010-05-01 |
| GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery (NCT00980343) | National Cancer Institute (NCI) | 2010-02-01 |
| Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas (NCT01024907) | Abramson Cancer Center at Penn Medicine | 2009-12-17 |
| Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma (NCT00650923) | National Cancer Institute (NCI) | 2008-07-01 |
| Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme (NCT00641706) | National Cancer Institute (NCI) | 2008-07-01 |
| Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme (NCT00540722) | National Cancer Institute (NCI) | 2008-01-01 |
| Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer (NCT00492089) | National Cancer Institute (NCI) | 2007-06-01 |
| Pazopanib in Treating Patients With Recurrent Glioblastoma (NCT00459381) | National Cancer Institute (NCI) | 2007-05-01 |
| Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor (NCT00638898) | City of Hope Medical Center | 2007-02-26 |
| Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma (NCT00379080) | National Cancer Institute (NCI) | 2007-01-01 |
| Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme (NCT00445588) | National Cancer Institute (NCI) | 2007-01-01 |
| VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide (NCT00369590) | National Cancer Institute (NCI) | 2006-08-01 |
| Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma (NCT00335764) | National Cancer Institute (NCI) | 2006-04-01 |
| AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00305656) | National Cancer Institute (NCI) | 2006-01-01 |
| Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme (NCT00238303) | National Cancer Institute (NCI) | 2005-09-01 |
| Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma (NCT00112736) | National Cancer Institute (NCI) | 2005-04-01 |
| FR901228 in Treating Patients With Recurrent High-Grade Gliomas (NCT00085540) | National Cancer Institute (NCI) | 2005-01-01 |
| Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme (NCT00112866) | National Cancer Institute (NCI) | 2005-01-01 |
| Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma (NCT00093613) | National Cancer Institute (NCI) | 2004-12-01 |
| Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00362921) | Duke University | 2004-04-01 |
| Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme (NCT00075491) | National Cancer Institute (NCI) | 2003-12-01 |
| Imatinib Mesylate in Treating Patients With Recurrent Meningioma (NCT00045734) | National Cancer Institute (NCI) | 2003-02-01 |
| A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas (NCT00045708) | National Cancer Institute (NCI) | 2002-10-01 |
| Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma (NCT00045110) | National Cancer Institute (NCI) | 2002-08-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00016328) | National Cancer Institute (NCI) | 2001-05-01 |
| Bortezomib in Treating Patients With Recurrent Glioma (NCT00006773) | National Cancer Institute (NCI) | 2001-05-01 |
| Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas (NCT02055196) | City of Hope Medical Center | |